NEWS1 wire brief. This page keeps the update readable on-site while clearly pointing to the original publisher for the full report.
India proposes immediate suspension of drug manufacturing licences for medicines failing government quality tests, tightening oversight and strengthening action against drugmakers.
India has proposed rules requiring regulators to immediately suspend manufacturing licences for medicines that fail specified quality standards in government testing, tightening oversight of one of t…
What we know
- Source: BusinessLine
- Byline: Reuters
- Published: 05 Nov 2026 00:06
This briefing is based on source metadata delivered through NewsAPI. Open the original publisher below for the full article and continuing updates.